Randomised, sham placebo controlled, parallel study of nCPAP on quality of life (SF36) in obstructive sleep apnoea.

Randomised, sham placebo controlled, parallel study of nCPAP on quality of life (SF36) in obstructive sleep apnoea.

Detalles Bibliográficos
Main Authors:	Stradling, JR, Jenkinson, C, Davies, R, Mullins, B
Formato:	Journal article
Publicado:	1999

Títulos similares

Randomised, sham-placebo, parallel study of Nasal Continuous Positive Airway Pressure (NCPAP) for the treatment of Obstructive Sleep Apnoea (OSA)
por: Stradling, JR, et al.
Publicado: (1998)

Randomised, sham placebo controlled study of nasal continuous positive airway pressure (NCPAP) on simulated steering in obstructive sleep apnoea (OSA).
por: Hack, M, et al.
Publicado: (1999)

Randomised, sham placebo, parallel study of the effect of Nasal Continuous Positive Airway Pressure (NCPAP) on steering performance in patients with Obstructive Sleep Apnoea (OSA) - interim analysis
por: Hack, M, et al.
Publicado: (1998)

Sleep fragmentation indices as predictors of daytime sleepiness and nCPAP response in obstructive sleep apnea.
por: Bennett, L, et al.
Publicado: (1998)

Quality of life before and after Nasal Continuous Positive Airway Pressure (NCPAP) treatment for Obstructive Sleep Apnoea (OSA)
por: Stradling, JR, et al.
Publicado: (1996)

Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial.
por: Jenkinson, C, et al.
Publicado: (1999)

Obstructive sleep apnoea - Reply
por: Stradling, JR, et al.
Publicado: (1999)

Performance of patients with Obstructive Sleep Apnoea (OSA) on a steering simulation after six months treatment with Nasal Continuous Positive Airway Pressure (NCPAP)
por: Hack, M, et al.
Publicado: (1999)

Performance of patients with obstructive sleep apnoea (OSA) on a steering simulation after six months treatment with nasal continuous positive airway pressure (NCPAP)
por: Hack, M, et al.
Publicado: (1999)

[Effect on quality of life of nCPAP treatment in patients with obstructive sleep apnea].
por: Mar, J, et al.
Publicado: (2005)

Blood pressure change after treatment for obstructive sleep apnoea (OSA) with continuous positive airway pressure (CPAP)
por: Pepperell, J, et al.
Publicado: (2000)

Is more NCPAP better?
por: Stradling, JR, et al.
Publicado: (2000)

Platelet activation is increased in obstructive sleep apnoea and does not fall with CPAP treatment
por: Robinson, G, et al.
Publicado: (2002)

Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea
por: Turnbull, C, et al.
Publicado: (2019)

Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial.
por: Pepperell, J, et al.
Publicado: (2002)

Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea.
por: Hack, M, et al.
Publicado: (2000)

Can autonomic arousals and neural net EEG analysis predict daytime sleepiness and its response to nCPAP in OSA?
por: Bennett, L, et al.
Publicado: (1997)

A randomised controlled trial of the effect of CPAP on diabetic macular oedema in people with concurrent obstructive sleep apnoea
por: West, SD, et al.
Publicado: (2018)

The Tongue Muscle Training (ZMT®) in nCPAP Patients with Obstructive Sleep Apnea Syndrome (OSAS)
por: Gessmann H.-W., et al.
Publicado: (2013-06-01)

CPAP THERAPY DOES NOT REDUCE SERUM URIC ACID LEVELS IN OBSTRUCTIVE SLEEP APNOEA
por: Prudon, B, et al.
Publicado: (2012)

The effects of supplemental oxygen on blood pressure in obstructive sleep apnoea during cpap withdrawal
por: Turnbull, C, et al.
Publicado: (2017)

Effect of CPAP on insulin resistance in patients with obstructive sleep apnoea and type 2 diabetes - Authors' reply
por: West, S, et al.
Publicado: (2008)

From CPAP to tailored therapy for obstructive sleep Apnoea
por: Kate Sutherland, et al.
Publicado: (2018-12-01)

Comparison of three ways to determine and deliver pressure during nasal CPAP therapy for obstructive sleep apnoea.
por: West, S, et al.
Publicado: (2006)

Effects of CPAP therapy withdrawal on exhaled breath pattern in obstructive sleep apnoea
por: Stradling, J, et al.
Publicado: (2015)

Effects of CPAP therapy withdrawal on exhaled breath pattern in obstructive sleep apnoea
por: Schwarz, EI, et al.
Publicado: (2015)

CPAP does not reduce 24 hour blood pressure in hypertensive obstructive sleep apnoea patients without daytime sleepiness
por: Robinson, G, et al.
Publicado: (2004)

Physiological consequences of CPAP therapy withdrawal in patients with obstructive sleep apnoea-An opportunity for an efficient experimental model
por: Schwarz, E, et al.
Publicado: (2018)

Early nCPAP versus intubation in very low birth weight infants
por: Pedro Neves Tavares, et al.
Publicado: (2013-06-01)

Long-term benefits in self-reported health status of nasal continuous positive airway pressure therapy for obstructive sleep apnoea.
por: Jenkinson, C, et al.
Publicado: (2001)

The effect of obstructive sleep apnoea on hypoxic and inflammatory markers during CPAP withdrawal: Further evidence from three randomised control trials
por: Turnbull, C, et al.
Publicado: (2016)

The effect of CPAP on insulin resistance and HbA1c in people with obstructive sleep apnoea and type 2 diabetes: A randomised controlled trial
por: West, S, et al.
Publicado: (2006)

Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis.
por: Schwarz, E, et al.
Publicado: (2015)

Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea.
por: Meston, N, et al.
Publicado: (2003)

Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis
por: Schwarz, E, et al.
Publicado: (2015)

Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA).
por: Robinson, G, et al.
Publicado: (2008)

NCPAP for the treatment of obstructive sleep apnea
por: Ademir Baptista Silva, et al.
Publicado: (1989-06-01)

Acute effects of obstructive sleep apnoea.
por: Davies, R, et al.
Publicado: (1993)

CPAP withdrawal as a model of the cardiovascular effects of obstructive sleep apnoea
por: Turnbull, C
Publicado: (2018)

Obstructive sleep apnoea.
por: Stradling, J
Publicado: (2007)